Theranostics
2023; 13(2):870.
doi:10.7150/thno.78981 This issueCite
Erratum
Employing Macrophage-Derived Microvesicle for Kidney-Targeted Delivery of Dexamethasone: An Efficient Therapeutic Strategy against Renal Inflammation and Fibrosis: Erratum
Tao-Tao Tang1, Lin-Li Lv1✉, Bin Wang1, Jing-Yuan Cao1, Ye Feng1, Zuo-Lin Li1, Min Wu1, Feng-Mei Wang1, Yi Wen1, Le-Ting Zhou1, Hai-Feng Ni1, Ping-Sheng Chen1, Ning Gu2, Steven D. Crowley3, Bi-Cheng Liu✉
1. Institute of Nephrology, Zhong Da Hospital, School of Medicine, Southeast University, Nanjing, China 2. State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Sciences and Medical Engineering, Southeast University, Nanjing, China 3. Division of Nephrology, Department of Medicine, Duke University and Durham VA Medical Centers, Durham, North Carolina, United States
✉ Corresponding authors: Bi-Cheng Liu (liubc64com) or Lin-Li Lv (lvlinliedu.cn).
Citation:
Tang TT, Lv LL, Wang B, Cao JY, Feng Y, Li ZL, Wu M, Wang FM, Wen Y, Zhou LT, Ni HF, Chen PS, Gu N, Crowley SD, Liu BC. Employing Macrophage-Derived Microvesicle for Kidney-Targeted Delivery of Dexamethasone: An Efficient Therapeutic Strategy against Renal Inflammation and Fibrosis: Erratum. Theranostics 2023; 13(2):870. doi:10.7150/thno.78981. https://www.thno.org/v13p0870.htm
Tang, T.T., Lv, L.L., Wang, B., Cao, J.Y., Feng, Y., Li, Z.L., Wu, M., Wang, F.M., Wen, Y., Zhou, L.T., Ni, H.F., Chen, P.S., Gu, N., Crowley, S.D., Liu, B.C. (2023). Employing Macrophage-Derived Microvesicle for Kidney-Targeted Delivery of Dexamethasone: An Efficient Therapeutic Strategy against Renal Inflammation and Fibrosis: Erratum. Theranostics, 13(2), 870. https://doi.org/10.7150/thno.78981.
ACS
Tang, T.T.; Lv, L.L.; Wang, B.; Cao, J.Y.; Feng, Y.; Li, Z.L.; Wu, M.; Wang, F.M.; Wen, Y.; Zhou, L.T.; Ni, H.F.; Chen, P.S.; Gu, N.; Crowley, S.D.; Liu, B.C. Employing Macrophage-Derived Microvesicle for Kidney-Targeted Delivery of Dexamethasone: An Efficient Therapeutic Strategy against Renal Inflammation and Fibrosis: Erratum. Theranostics 2023, 13 (2), 870. DOI: 10.7150/thno.78981.
NLM
Tang TT, Lv LL, Wang B, Cao JY, Feng Y, Li ZL, Wu M, Wang FM, Wen Y, Zhou LT, Ni HF, Chen PS, Gu N, Crowley SD, Liu BC. Employing Macrophage-Derived Microvesicle for Kidney-Targeted Delivery of Dexamethasone: An Efficient Therapeutic Strategy against Renal Inflammation and Fibrosis: Erratum. Theranostics 2023; 13(2):870. doi:10.7150/thno.78981. https://www.thno.org/v13p0870.htm
CSE
Tang TT, Lv LL, Wang B, Cao JY, Feng Y, Li ZL, Wu M, Wang FM, Wen Y, Zhou LT, Ni HF, Chen PS, Gu N, Crowley SD, Liu BC. 2023. Employing Macrophage-Derived Microvesicle for Kidney-Targeted Delivery of Dexamethasone: An Efficient Therapeutic Strategy against Renal Inflammation and Fibrosis: Erratum. Theranostics. 13(2):870.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Global reach, higher impact
